In non-GATA2 mutated MDS rheumatologic disorders usually develop months/years after MDS diagnosis, whereas in GATA2 deficiency they can develop independently from hematological manifestations even without any other clinical symptom (40). The gene discussed is GATA2; the disease is hyperinsulinemic hypoglycemia, familial, 4.